Skip to content

Clinical trials

Adenocarcinoma of Lung trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20071
20091
20111
20122
20131
20171
20202
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology4
Novartis Pharmaceuticals4
Amgen1
AstraZeneca1
Cancer Therapeutics Research Group1
Eastern Cooperative Oncology Group1
Gustave Roussy, Cancer Campus, Grand Paris1
Imugene Limited1
Morphotek1
Multitude Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung18
Carcinoma, Non-Small-Cell Lung14
Lung Neoplasms12
Adenocarcinoma, Bronchiolo-Alveolar5
Endometrial Neoplasms3
Ovarian Neoplasms3
Carcinoma, Ovarian Epithelial2
Melanoma2
Triple Negative Breast Neoplasms2
Breast Neoplasms1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.